ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study.

E.F. Smit, K. Mattson, J. van Pawel, C Manegold, S Clarke, P.E. Postmus

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)455-60
JournalAnnals of Oncology
Volume14
Issue number3
DOIs
Publication statusPublished - 2003

Cite this